Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure

Recruiting Observational Study
Pre-Eclampsia; Complicating Pregnancy Antiphospholipid Syndrome in Pregnancy Pulmonary Hypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Female
Study type
Observational
Participants needed
900 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary goal of this observational study is to learn about postpartum pulmonary artery pressure in women who suffered from Preeclampsia and Antiphospholipid Syndrome. The main question it aims to answer is whether the conjunction of preeclampsia with obstetric antiphospholipid syndrome significantly foster the development of long-lasting pulmonary hypertension. Only participants who suffered…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: \> 16 years. * Consent or waiver of consent according Chapter 9 * Preeclampsia Defined as: • New onset hypertension (blood pressure \>140/90mmHg on multiple occasions after 20 weeks of gestation) In combination with new onset of 1 or more of the following: * Proteinur…
Contacts

Emrush Rexhaj, MD

+41 31 632 21 11

emrush.rexhaj@insel.ch

CONTACT